U.S. market Closed. Opens in 25 minutes

KNTE | Kinnate Biopharma Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
RevenueN/AN/AN/AN/AN/AN/A
Cost of Revenue799.00K604.00K123.00K83.00KN/AN/A
Gross Profit-799.00K-604.00K-123.00K-83.00KN/AN/A
Operating Expenses118.21M118.52M90.11M36.00M12.01M7.63M
Selling, General & Admin27.44M30.37M22.95M6.76M3.06M1.96M
Research & Development90.77M88.15M67.17M29.24M8.96M5.67M
Other Operating ExpensesN/A2.25M348.00K-5.00KN/AN/A
Operating Income-119.01M-118.52M-90.11M-36.00M-12.01M-7.63M
Other Expenses / Income6.36M2.25M348.00K240.00K43.00KN/A
Before Tax Income-112.65M-116.27M-89.76M-35.76M-11.97M-7.63M
Income Tax ExpensesN/A-2.25M-348.00K-328.00K-43.00KN/A
Net Income-112.65M-114.02M-89.42M-35.43M-11.93M-7.63M
Interest ExpensesN/A-2.25MN/AN/AN/AN/A
Basic Shares Outstanding46.58M44.07M43.60M43.48M43.33M10.80M
Diluted Shares Outstanding46.58M44.07M43.60M43.48M43.33M10.80M
EBITDA-118.21M-117.92M-89.99M-36.00M-12.01M-7.63M
EBITDA Margin0.00%0.00%0.00%0.00%0.00%0.00%
EBIT-112.65M-118.52M-89.76M-35.76M-11.97M-7.63M
EBIT Margin0.00%0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙